Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxepin for Esophagitis-Induced Pain in Thoracic Radiotherapy
NCT02062632Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Apr 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of doxepin in esophagitis (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in Mouth Pain as Measured by Average Area Under the Curve Per Assessment. Started Apr 2014; status: terminated.
02
Drugs
doxepin
03
Conditions
esophagitis
Beyond the preview
Go deeper on NCT02062632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062632.